Trial Profile
A Pilot Multicenter, Randomized, Double-Blind Study Comparing The Proportion Of Responders to PSD502 and to Placebo Using the PEBEQ In Subjects With Premature Ejaculation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2022
Price :
$35
*
At a glance
- Drugs Lidocaine/prilocaine (Primary)
- Indications Premature ejaculation
- Focus Therapeutic Use
- Sponsors Plethora Solutions
- 30 Jun 2022 Status changed from active, no longer recruiting to completed.
- 19 May 2021 Planned End Date changed from 31 Jan 2021 to 30 Jun 2021.
- 28 Oct 2020 Planned End Date changed from 31 Dec 2020 to 31 Jan 2021.